Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 18) (2021) Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results, AMERICAN JOURNAL OF HEMATOLOGY, vol. 96, br. 9, str. 1156-1165 (Article) 

Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 18) (2017) Outcomes after 18 months of eliglustat therapy in treatment-naive adults with Gaucher disease type 1: The phase 3 ENGAGE trial, AMERICAN JOURNAL OF HEMATOLOGY, vol. 92, br. 11, str. 1170-1176 (Article) 

Mistry Pramod K,...,Petakov Milan S,...,(broj koautora 21) (2015) Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 The ENGAGE Randomized Clinical Trial, JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol. 313, br. 7, str. 695-706 (Article)